|
1
|
Abreu LP, Kruger E and Tennant M: Oral
cancer in Western Australia, 1982–2006: A retrospective
epidemiological study. J Oral Pathol Med. 39:376–381.
2010.PubMed/NCBI
|
|
2
|
Mignogna MD, Fedele S and Lo Russo L: The
World Cancer Report and the burden of oral cancer. Eur J Cancer
Prev. 13:139–142. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kademani D, Bell RB, Bagheri S, et al:
Prognostic factors in intraoral squamous cell carcinoma: the
influence of histologic grade. J Oral Maxillofac Surg.
63:1599–1605. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fire A, Xu S, Montgomery MK, Kostas SA,
Driver SE and Mello CC: Potent and specific genetic interference by
double-stranded RNA in Caenorhabditis elegans. Nature. 391:806–811.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
July LV, Beraldi E, So A, Fazli L, Evans
K, English JC and Gleave ME: Nucleotide-based therapies targeting
clusterin chemosensitize human lung adenocarcinoma cells both in
vitro and in vivo. Mol Cancer Ther. 3:223–232. 2004.PubMed/NCBI
|
|
6
|
Karasarides M, Chiloeches A, Hayward R,
Niculescu-Duvaz D, Scanlon I, Friedlos F, Ogilvie L, Hedley D,
Martin J, Marshall CJ, et al: B-RAF is a therapeutic target in
melanoma. Oncogene. 23:6292–6298. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vaupel P, Kallinowski F and Okunieff P:
Blood flow, oxygen and nutrient supply, and metabolic
microenvironment of human tumors: A review. Cancer Res.
49:6449–6465. 1989.PubMed/NCBI
|
|
8
|
Höckel M, Schlenger K, Mitze M, Schäffer U
and Vaupel P: Hypoxia and radiation response in human tumors. Semin
Radiat Oncol. 6:3–9. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Höckel M and Vaupel P: Tumor hypoxia:
Definitions and current clinical, biologic, and molecular aspects.
J Natl Cancer Inst. 93:266–276. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Semenza GL and Wang GL: A nuclear factor
induced by hypoxia via de novo protein synthesis binds to the human
erythropoietin gene enhancer at a site required for transcriptional
activation. Mol Cell Biol. 12:5447–5454. 1992.PubMed/NCBI
|
|
11
|
Semenza GL: Hypoxia-inducible factor 1:
Master regulator of O2 homeostasis. Curr Opin Genet Dev.
8:588–594. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kallio PJ, Pongratz I, Gradin K, McGuire J
and Poellinger L: Activation of hypoxia-inducible factor 1alpha:
Posttranscriptional regulation and conformational change by
recruitment of the Arnt transcription factor. Proc Natl Acad Sci
USA. 94:5667–5672. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Salceda S and Caro J: Hypoxia-inducible
factor 1alpha (HIF-1alpha) protein is rapidly degraded by the
ubiquitin-proteasome system under normoxic conditions. Its
stabilization by hypoxia depends on redox-induced changes. J Biol
Chem. 272:22642–22647. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ema M, Hirota K, Mimura J, Abe H, Yodoi J,
Sogawa K, Poellinger L and Fujii-Kuriyama Y: Molecular mechanisms
of transcription activation by HLF and HIF1alpha in response to
hypoxia: Their stabilization and redox signal-induced interaction
with CBP/p300. EMBO J. 18:1905–1914. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lando D, Peet DJ, Whelan DA, Gorman JJ and
Whitelaw ML: Asparagine hydroxylation of the HIF transactivation
domain a hypoxic switch. Science. 295:858–861. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Semenza GL: Targeting HIF-1 for cancer
therapy. Nat Rev Cancer. 3:721–732. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhong H, De Marzo AM, Laughner E, Lim M,
Hilton DA, Zagzag D, Buechler P, Isaacs WB, Semenza GL and Simons
JW: Overexpression of hypoxia-inducible factor 1alpha in common
human cancers and their metastases. Cancer Res. 59:5830–5835.
1999.PubMed/NCBI
|
|
18
|
Talks KL, Turley H, Gatter KC, Maxwell PH,
Pugh CW, Ratcliffe PJ and Harris AL: The expression and
distribution of the hypoxia-inducible factors HIF-1alpha and
HIF-2alpha in normal human tissues, cancers, and tumor-associated
macrophages. Am J Pathol. 157:411–421. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liang X, Zheng M, Jiang J, Zhu G, Yang J
and Tang Y: Hypoxia-inducible factor-1 alpha, in association with
TWIST2 and SNIP1, is a critical prognostic factor in patients with
tongue squamous cell carcinoma. Oral Oncol. 47:92–97. 2011.
View Article : Google Scholar
|
|
20
|
Zhou H, Fei W, Bai Y, et al: RNA
interference-mediated downregulation of hypoxia-inducible
factor-1alpha inhibits angiogenesis and survival of oral squamous
cell carcinoma in vitro and in vivo. Eur J Cancer Prev. 21:289–299.
2012. View Article : Google Scholar
|
|
21
|
Kang FW, Gao Y, Que L, Sun J and Wang ZL:
Hypoxia-inducible factor-1α overexpression indicates poor clinical
outcomes in tongue squamous cell carcinoma. Exp Ther Med.
5:112–118. 2013.
|
|
22
|
Krishnamachary B, Berg-Dixon S, Kelly B,
Agani F, Feldser D, Ferreira G, Iyer N, LaRusch J, Pak B, Taghavi
P, et al: Regulation of colon carcinoma cell invasion by
hypoxia-inducible factor 1. Cancer Res. 63:1138–1143.
2003.PubMed/NCBI
|
|
23
|
Wang GL, Jiang BH, Rue EA and Semenza GL:
Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS
heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci
USA. 92:5510–5514. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang GL and Semenza GL: Desferrioxamine
induces erythropoietin gene expression and hypoxia-inducible factor
1 DNA-binding activity: Implications for models of hypoxia signal
transduction. Blood. 82:3610–3615. 1993.PubMed/NCBI
|
|
25
|
Kang FW, Que L, Wu M, Wang ZL and Sun J:
Effects of trichostatin A on HIF-1α and VEGF expression in human
tongue squamous cell carcinoma cells in vitro. Oncol Rep.
28:193–199. 2012.PubMed/NCBI
|
|
26
|
Jiang L, Peng WW, Li LF, Du R, Wu TT, Zhou
ZJ, Zhao JJ, Yang Y, Qu DL and Zhu YQ: Effects of deferoxamine on
the repair ability of dental pulp cells in vitro. J Endod.
40:1100–1104. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Carmeliet P, Dor Y, Herbert JM, Fukumura
D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R,
Maxwell P, et al: Role of HIF-1alpha in hypoxia-mediated apoptosis,
cell proliferation and tumour angiogenesis. Nature. 394:485–490.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Beasley NJ, Leek R, Alam M, Turley H, Cox
GJ, Gatter K, Millard P, Fuggle S and Harris AL: Hypoxia-inducible
factors HIF-1alpha and HIF-2alpha in head and neck cancer:
Relationship to tumor biology and treatment outcome in surgically
resected patients. Cancer Res. 62:2493–2497. 2002.PubMed/NCBI
|
|
29
|
Akakura N, Kobayashi M, Horiuchi I, Suzuki
A, Wang J, Chen J, Niizeki H, Kawamura Ki, Hosokawa M and Asaka M:
Constitutive expression of hypoxia-inducible factor-1alpha renders
pancreatic cancer cells resistant to apoptosis induced by hypoxia
and nutrient deprivation. Cancer Res. 61:6548–6554. 2001.PubMed/NCBI
|
|
30
|
Serrano M, Hannon GJ and Beach D: A new
regulatory motif in cell-cycle control causing specific inhibition
of cyclin D/CDK4. Nature. 366:704–707. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hammer S, To KK, Yoo YG, Koshiji M and
Huang LE: Hypoxic suppression of the cell cycle gene CDC25A in
tumor cells. Cell Cycle. 6:1919–1926. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Goda N, Dozier SJ and Johnson RS: HIF-1 in
cell cycle regulation, apoptosis, and tumor progression. Antioxid
Redox Signal. 5:467–473. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Graeber TG, Peterson JF, Tsai M, Monica K,
Fornace AJ Jr and Giaccia AJ: Hypoxia induces accumulation of p53
protein, but activation of a G1-phase checkpoint by low-oxygen
conditions is independent of p53 status. Mol Cell Biol.
14:6264–6277. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tsai YP and Wu KJ: Hypoxia-regulated
target genes implicated in tumor metastasis. J Biomed Sci.
19:1022012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fujiwara S, Nakagawa K, Harada H, Nagato
S, Furukawa K, Teraoka M, Seno T, Oka K, Iwata S and Ohnishi T:
Silencing hypoxia-inducible factor-1alpha inhibits cell migration
and invasion under hypoxic environment in malignant gliomas. Int J
Oncol. 30:793–802. 2007.PubMed/NCBI
|
